| Financial Year |
March 31 2023 |
| Monetary Funds |
26,237,783,140.52 |
| Held-for-trading Financial Assets |
489,346,119.91 |
| Notes Receivable |
2,397,426,344.76 |
| Accounts Receivable |
5,773,815,896.05 |
| Advances to Suppliers |
2,386,803,449.63 |
| Other Receivables |
2,244,499,762.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
23,974,965,283.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,910,625,702.27 |
| Other Current Assets |
7,537,622,453.12 |
| Total Current Assets |
98,709,707,763.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,736,889,601.79 |
| Long-term Equity Investment |
10,486,675,623.89 |
| Investment Properties |
425,556,726.33 |
| Fixed Assetes |
26,559,350,062.46 |
| Under-construction Projects |
8,999,232,895.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,209,162,914.36 |
| R&D expenses |
12,872,819,750.25 |
| Goodwill |
27,763,359.77 |
| Long-Term Deferred and Prepaid Expenses |
253,817,359.85 |
| Deferred Income Tax Assets |
3,742,059,888.49 |
| Other Non-Current Assets |
3,448,397,610.41 |
| Sub-Total of Non-Current Assets |
79,388,448,818.71 |
| Total Assets |
178,098,156,581.98 |
| Short-Term Loans |
4,008,390,721.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,641,157,224.32 |
| Accounts Payable |
25,896,500,953.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,239,820,531.39 |
| Taxes Payable |
2,124,013,065.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,628,381,850.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,771,633,237.66 |
| Other Current Liabilities |
5,682,204,186.83 |
| Sub-Total of Current Liabilities |
90,644,042,817.25 |
| Long-term Loans |
15,192,814,046.07 |
| Bonds Payable |
3,486,893,798.16 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
860,681,738.77 |
| Other Non-Current Liabilities |
47,322,485.00 |
| Sub-Total of Non-Current Liabilities |
24,117,152,355.93 |
| Total Liabilities |
114,761,195,173.18 |
| Paid-In Capital(Or Share Stock) |
8,486,559,196.00 |
| Capital Surplus |
2,325,423,852.64 |
| Surplus Reserve |
4,580,997,542.09 |
| LESS:Treasury Stock |
1,660,583,280.24 |
| Undistributed Profits |
49,351,655,538.53 |
| Minority Stockholder's Interest |
12,729,247.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
63,324,232,161.25 |
| Owner's Equity（Stockholder's Equity） |
63,336,961,408.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
178,098,156,581.98 |
